BiotechTube
Home/Viracta Therapeutics/Ivor Royston
IR

Ivor Royston

Former CEO, President, and Co-Founder

Viracta Therapeutics

Therapeutic Areas

OncologyInfectious Disease (Virus-associated)

Viracta Therapeutics Pipeline

DrugIndicationPhase
Nanatinostat + Valganciclovir (Nana-val)Relapsed/Refractory EBV+ Lymphomas (PTCL, CTCL, DLBCL)Phase 2

Leadership Team at Viracta Therapeutics

DP
Darrel P. Cohen
Former Chief Medical Officer
MR
Mark Rothera
Former President and CEO
DR
Daniel R. Chevallard
Former COO and CFO
JK
John K. H. North
Former Chairman of the Board
View full Viracta Therapeutics profile